Jason has spent over 18 years in the consulting industry, with 8 years focused on the commercial strategy and operations of biopharma companies. Prior to joining Asymmetry Group, Jason held senior commercial strategy roles at Syneos Health, Envision Pharma Group, and Align Strategy where he advised biopharma companies on launch strategy and planning, brand strategy, competitive strategy, and product lifecycle management. Jason also previously served as a Vice President at Analysis Group where he advised biopharma companies engaged in government investigations and corporate litigation related to antitrust issues, off-label marketing allegations, False Claims Act and Anti-kickback Statute investigations.
Jason has a broad array of experience supporting biopharma clients in developing their commercial strategies, including developing launch and go-to-market strategies, developing brand and portfolio strategy, preparing competitive response to changing market dynamics, and managing the lifecycle of an asset. Jason has partnered with senior client executives to assess strategic opportunities, lead end-to-end project execution, and deliver on complex, high-impact initiatives.
Jason holds a MS in Finance from Brandeis University’s International Business School and a BA in Economics from Stonehill College.